ETA receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinaseindependent pathway
Am. Evans et al., ETA receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinaseindependent pathway, BR J PHARM, 127(1), 1999, pp. 153-160
1 We have investigated the possibility that ET-1 can induce an increase in
myofilament calcium sensitivity in pulmonary artery smooth muscle. Arterial
rings were permeabilized using a-toxin (120 mu g ml(-1)), in the presence
of A23187 (10 mu M) to 'knock out' Ca2+ stores, and pre-constricted with pC
a 6.8 (buffered with 10 mM EGTA). In the presence of this fixed Ca2+ concen
tration, 1 mu M ET-I induced a sustained, reversible constriction of 0.15 m
N.
2 Pulmonary arterial rings were freeze-clamped at the peak of the induced c
onstriction (time matched). Subsequent densitometric analysis revealed that
ET-I (1 mu M) increased the level of phosphorylated myosin light chains by
34% compared to an 11% increase in the presence of pCa 6.8 alone.
3 In contrast to ET-1, the selective ETB receptor agonist Sarafotoxin S6C (
100 nh I) failed to induce a significant constriction.
4 The constriction induced by 1 mu M ET-I was reversibly inhibited when the
preparation was preincubated (15 min) with the ETA receptor antagonist BQ
123 (100 mu M). The constriction measured 0.13 mN in the absence and 0.07 m
N in the presence of 100 mu M BQ 123.
5 In contrast, the constriction induced by 1 mu M ET-I measured 0.19 mN in
the absence and 0.175 mN following a 15 min pre-incubation with the ETB ant
agonist BQ 788 (100 mu M).
6 The constriction induced by 1 mu M ET-I measured 0.14 mN in the presence
and 0.13 mN following pre-incubation with the tyrosine kinase inhibitor Tyr
phostin A23 (100 mu M).
7 We conclude that ET-1 induced an increase in myofilament calcium sensitiv
ity in rat pulmonary arteries via the activation of ETA receptors and by a
mechanism(s) independent of tyrosine kinase.